Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gattermann

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 13, 1996
[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome]C Aul, U Germing, N Gattermann, et al.
Leukemia & Lymphoma|March 23, 2002
Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reportsC Strupp, M Aivado, U Germing, et al.
American Journal of Hematology|January 1, 1997
Recurrent reversible nephrotic syndrome during therapy with recombinant interferon alphaC Aul, H Minning, T Südhoff, et al.
British Journal of Haematology|May 3, 2000
Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinctionU Germing, N Gattermann, M Aivado, et al.
Leukemia Research|November 15, 2000
Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literatureC Strupp, U Germing, I Trommer, et al.
European Journal of Biochemistry|December 16, 1998
MtDNA mutations associated with sideroblastic anaemia cause a defect of mitochondrial cytochrome c oxidaseS Bröker, B Meunier, P Rich, et al.
Lancet (London, England)|April 29, 1995
No improvement of refractory sideroblastic anaemia with ubidecarenoneN Gattermann, K Briviba, A Tsamaloukas, et al.
American Journal of Hematology|January 12, 1999
The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemiaY L Wang, H K Choi, C Aul, et al.
Leukemia|November 1, 1994
Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf scoreC Aul, N Gattermann, U Germing, et al.
Leukemia Research|June 28, 2005
Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomideC Strupp, R Fenk, A Kündgen, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Deutsche Medizinische Wochenschrift (1946)|September 13, 1996
[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome]C Aul, U Germing, N Gattermann, et al.
Leukemia & Lymphoma|March 23, 2002
Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reportsC Strupp, M Aivado, U Germing, et al.
American Journal of Hematology|January 1, 1997
Recurrent reversible nephrotic syndrome during therapy with recombinant interferon alphaC Aul, H Minning, T Südhoff, et al.
British Journal of Haematology|May 3, 2000
Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinctionU Germing, N Gattermann, M Aivado, et al.
Leukemia Research|November 15, 2000
Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literatureC Strupp, U Germing, I Trommer, et al.
European Journal of Biochemistry|December 16, 1998
MtDNA mutations associated with sideroblastic anaemia cause a defect of mitochondrial cytochrome c oxidaseS Bröker, B Meunier, P Rich, et al.
Lancet (London, England)|April 29, 1995
No improvement of refractory sideroblastic anaemia with ubidecarenoneN Gattermann, K Briviba, A Tsamaloukas, et al.
American Journal of Hematology|January 12, 1999
The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemiaY L Wang, H K Choi, C Aul, et al.
Leukemia|November 1, 1994
Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf scoreC Aul, N Gattermann, U Germing, et al.
Leukemia Research|June 28, 2005
Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomideC Strupp, R Fenk, A Kündgen, et al.
Pageof 11